| 000 | 01732 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250513071156.0 | ||
| 264 | 0 | _c19940217 | |
| 008 | 199402s 0 0 eng d | ||
| 022 | _a1043-0342 | ||
| 024 | 7 |
_a10.1089/hum.1993.4.5-659 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWalker, R | |
| 245 | 0 | 0 |
_aA study of the safety and survival of the adoptive transfer of genetically marked syngeneic lymphocytes in HIV-infected identical twins. _h[electronic resource] |
| 260 |
_bHuman gene therapy _cOct 1993 |
||
| 300 |
_a659-80 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAminohydrolases _xgenetics |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 | _aCell Survival |
| 650 | 0 | 4 | _aClinical Protocols |
| 650 | 0 | 4 | _aDNA Primers |
| 650 | 0 | 4 |
_aDiseases in Twins _xtherapy |
| 650 | 0 | 4 | _aFeasibility Studies |
| 650 | 0 | 4 | _aGenetic Therapy |
| 650 | 0 | 4 |
_aHIV Infections _ximmunology |
| 650 | 0 | 4 | _aHIV Seronegativity |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy, Adoptive |
| 650 | 0 | 4 | _aLymphocyte Activation |
| 650 | 0 | 4 | _aLymphocyte Transfusion |
| 650 | 0 | 4 | _aMacaca mulatta |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 | _aSafety |
| 650 | 0 | 4 | _aTwins, Monozygotic |
| 700 | 1 | _aBlaese, R M | |
| 700 | 1 | _aCarter, C S | |
| 700 | 1 | _aChang, L | |
| 700 | 1 | _aKlein, H | |
| 700 | 1 | _aLane, H C | |
| 700 | 1 | _aLeitman, S F | |
| 700 | 1 | _aMullen, C A | |
| 700 | 1 | _aLarson, M | |
| 773 | 0 |
_tHuman gene therapy _gvol. 4 _gno. 5 _gp. 659-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/hum.1993.4.5-659 _zAvailable from publisher's website |
| 999 |
_c8280085 _d8280085 |
||